Leptin-melanocortin system, body weight regulation and obesity;Sistema leptina-melanocortinas en la regulación de la ingesta y el peso corporal

Revista Medica de Chile

Volumn 137, Issue 9, 2009, Pages 1225-1234

  Santos M, José Luis ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Leptin; Melanocortins; Obesity

Indexed keywords

LEPTIN; MELANOCORTIN;

ANIMAL; ARTICLE; BODY WEIGHT; GENETICS; HUMAN; MOUSE; MUTATION; OBESITY; PHYSIOLOGY;

ANIMALS; BODY WEIGHT; HUMANS; LEPTIN; MELANOCORTINS; MICE; MUTATION; OBESITY;

EID: 70450183813     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. CLEMENT K., SORENSEN T.I.A. Obesity: genomics and postgenomics. Informa Healthcare. New York 2007.
2. Farooqi I.S., O'Rahilly S. Monogenic obesity in humans. Annu Rev Med 2005; 56: 443-58.
3. RANKINEN T., ZUBERI A., CHAGNON Y.C., WEISNAGEL S.J., ARGYROPOULOS G., WALTS B., ET AL. The human obesity gene map: the 2005 update. Obesity 2006; 14: 529-644.
4. FAROOQI I.S., O'RAHILLY S. Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr 2009 (Suppl); 89: 980S-984S.
5. CONE R.D. Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005; 8: 571-8.
6. SEELEY R.J., DRAZEN D.L., CLEGG D.J. The critical role of the melanocortin system in the control of energy intake. Annu Rev Nutr 2004; 24: 133-49.
7. INGALLS A.M., DICKIE M.D., SNELL G.D. Obese, new mutation in the mouse. J Hered 1950; 41: 317-8.
8. ZHANG Y., PROENCA R., MAFFEI M., BARONE M., LEOPOLD L., FRIEDMAN J.M. ET AL. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
9. HALAAS J.L., GAJIWALA K.S., MAFFEI M., COHEN S.L., CHAIT B.T., RABINOWITZ D. ET AL. Weight reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-6.
10. PINTO S., ROSEBERRY A.G., LIU H., DIANO S., SHANABROUGH M., CAI X. ET AL. Rapid Rewiring of Arcuate Nucleus Feeding Circuits by Leptin. Science 2004; 304: 110-5.
11. CHUA, S.C., CHUNG W.K., WU-PENG X.S. ET AL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (Leptin) receptor. Science 1996; 271: 994-6.
12. MONTAGUE C.T., FAROOQI I.S., WHITEHEAD J.P., SOOS M.A., RAU H., WAREHAM N.J. ET AL. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-8.
13. STROBEL A., ISSAD T., CAMOIN L., OZATA M., STROSBERG A.D. A leptin missense mutation associated with hypogo-nadism and morbid obesity. Nat Genet 1998; 18: 213-5.
14. FAROOQI I.S., JEBB S.A., LANGMACK G., LAWRENCE E., CHEETHAM C.H., PRENTICE A.M. ET AL. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341: 879-84.
15. FAROOQI I.S., BULLMORE E., KEOGH J., GILLARD J., O'RAHIELLY S., FLETCHER P.C. ET AL. Leptin regulates striatal regions and human eating behavior. Science 2007; 317: 1355.
16. CLÉMENT K., VAISSE C., LAHLOU N., CABROL S., PELLOUX V., CASSUTO D. ET AL. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392: 398-401.
17. FAROOQI I.S., WANGENSTEEN T., COLLINS S., KIMBER W., MATARESE G., KEOGH J.M. ET AL. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 2007; 356: 237-47.
18. LEE G.H., PROENCA R., MONTEZ J.M., CARROLL K.M., DARVISHZADEH J.G., LEE J.I. ET AL. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379: 632-5.
19. BATES S.H., STEARNS W.H., DUNDON T.A., SCHUBERT M., TSO A.W., WANG Y. ET AL. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 2003; 421: 856-9.
20. GAO Q., WOLFGANG M.J., NESCHEN S., MORINO K., HORVATH T.L., SHULMAN G.I. ET AL. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci USA 2004; 101: 4661-6.
21. OSWAL A., YEO G.S.H. The leptin melanocortin pathway and the control of body weight: lessons from human and murine genetics. Obes Rev 2007; 8: 293-306.
22. NISWENDER K.D., MORTON G.J., STEARNS W.H., RHODES C.J., MYERS M.G. JR, SCHWARTZ M.W. ET AL. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 2001; 413: 794-5.
23. WITHERS D.J., GUTIERREZ J.S., TOWERY H., BURKS D.J., REN J.M., PREVIS S. ET AL. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998; 391: 900-4
24. DUAN C., LI M., RUI L. SH2-B promotes insulin receptor substrate (IRS)1- and IRS2-mediated activation of the phosphatidylinositol 3-kinase pathway in response to leptin. J Biol Chem 2004; 279: 43684-91.
25. REN D., LI M., DUAN C., RUI L. Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. Cell Metab 2005; 2: 95-104.
26. XU A.W., KAELIN C.B., TAKEDA K., AKIRA S., SCHWARTZ M.W., BARSH G.S. ET AL. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J Clin Invest 2005; 115: 951-8.
27. GANTZ I., FONG T.M. The melanocortin system. Am J Physiol Endocrinol Metab 2003; 284: E468-E474.
28. HUSZAR D., LYNCH C.A., FAIRCHILD-HUNTRESS V., DUNMORE J.H., FANG Q., BERKEMEIER L.R. ET AL. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88: 131-41.
29. FAROOQI I.S., ÓRAHILLY S. Mutations in ligands and receptor of the leptin-melanocortin pathway that lead to obesity. Nat Clin Pract 2008; 4: 569-77.
30. SANTOS J.L., AMADOR P., VALLADARES M., ALBALA C., MARTINEZ J.A., MARTI A. Obesity and eating behaviour in a three- generation Chilean family with carriers of the Thr150Ile mutation in the melanocortin-4 receptor gene. J Physiol Biochem 2008; 64: 205-10.
31. DEMPFLE A., HINNEY A., HEINZEL-GUTENBRUNNER M., RAAB M., GELLER F., GUDERMANN T. ET AL. Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index. J Med Genet 2004; 41: 795-800.
32. CHEN A.S., MARSH D.J., TRUMBAUER M.E., FRAZIER E.G., GUAN X.M., YU H. ET AL. Inactivation of the mouse melanocor-tin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 2000; 26: 97-102.
33. BUTLER A. The melanocortin system and energy balance. Peptides 2006; 27: 281-90.
34. MENCARELLI M., WALKER G.E., MAESTRINI S., ALBERTI L., VERTI B., BRUNANI A. ET AL. Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. Eur J Hum Genet 2008; 16: 581-6.
35. YASWEN L., DIEHL N., BRENNAN M.B., HOCHGESCHWENDER U. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 1999; 5: 1066-70.
36. COLL A.P., FAROOQI I.S., CHALLIS B.G., YEO G.S., O'RAHILLY S. Proopiomelanocortin and energy balance: insights from human and murine genetics. J Clin Endocrinol Metab 2004; 89: 2557-62.
37. KRUDE H., BIEBERMANN H., SCHNABEL D., TANSEK M.Z., THEUNISSEN P., MULLIS P.E. ET AL. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 2003; 88: 4633-40.
38. LEE Y.S., CHALLIS B.G., THOMPSON D.A., YEO G.S., KEOGH J.M., MADONNA M.E. ET AL. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab 2006; 3: 135-40.
39. MILLINGTON G.W.M. The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutr Metab 2007; 4: 18.
40. JACKSON R.S., CREEMERS J.W., FAROOQI I.S., RAFFIN-SANSON M.L., VARRO A., DOCKRAY G.J. ET AL. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest 2003; 112: 1550-60.
41. ZHU X., ZHOU A., DEY A., NORRBOM C., CARROLL R., ZHANG C. ET AL. Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine pep-tide processing defects. Proc Natl Acad Sci USA 2002; 99: 10293-8.
42. NAGGERT J.K., FRICKER L.D., VARLAMOV O., NISHINA P.M., ROUILLE Y., STEINER D.F. ET AL. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 1995; 10: 135-42.
43. BARSH G. From Agouti to Pomc-100 years of fat blonde mice. Nat Med 1999; 5: 984-5.
44. MILTENBERGER R.J., MYNATT R.L., WILKINSON E., WOYCHIK R. The Role of the agouti Gene in the Yellow Obese Syndrome. J Nutr 1997, 127: 1902S-1907S.
45. JIRTLE R.L., SKINNER M.K. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007; 8: 253-62.
46. STUTZ A., MORRISON C., ARGYROPOULOS G. The Agoutirelated protein and its role in energy homeostasis. Peptides 2005; 26: 1771-81.
47. LUQUET S., PÉREZ F.A., HNASKO T.S., PALMITER R.D. NPY/ AGRP neurons are essential for feeding in adult mice but can be ablated in neonates. Science 2005; 310: 683-5.
48. COWLEY M.A., SMART J.L., RUBINSTEIN M., CERDÁN M.G., DIANO S., HORVATH T.L. ET AL. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001; 411: 480-4.
49. BALTHASAR N., COPPARI R., MCMINN J., LIU S.M., LEE C.E., TANG V. ET AL. Leptin receptor signalling in POMC neurons is required for normal body weight homeostasis. Neuron 2004; 42: 983-91.
50. SUTTON G.M., DUOS B., PATTERSON L.M., BERTHOUD H.R. Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signaling in rat solitary nucleus. Endocrinology 2005; 146: 3739-47.
51. HEISLER L.K., JOBST E.E., SUTTON G.M., ZHOU L., BOROK E., THORNTON-JONES Z. ET AL. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 2006; 51: 239-49.
52. MYERS M.G. Keeping the fat off with nesfatin. Nat Med 2006; 12: 1248-9.
53. XU B., GOULDING E.H., ZANG K., CEPOI D., CONE R.D., JONES K.R. ET AL. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 2003; 6: 736-42.
54. UNGER T.J., CALDERON G.A., BRADLEY L.C., SENA-ESTEVES M., RIOS M. Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J Neurosci 2007; 27: 14265-74.
55. GRAY J., YEO G.S., COX J.J., MORTON J., ADLAM A.L., KEOGH J.M. ET AL. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 2006; 55: 3366-71.
56. HAN J.C., LIU Q.R., JONES M., LEVINN R.L., MENZIE C.M., JEFFERSON-GEORGE K.S. ET AL. Brain-derived neurotrophic factor in the WAGR syndrome. N Engl J Med 2008; 359: 918-27.
57. YEO G.S., CONNIE HUNG C.C., ROCHFORD J., KEOGH J., GRAY J., SIVARAMAKRISHNAN S. ET AL. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci 2004; 7: 1187-9.
58. CONSIDINE R.V., SINHA M.K., HEIMAN M.L., KRIAUCIUNAS A., STEPHENS T.W., NYCE M.R. ET AL. Serum immunoreactiveleptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-5.
59. MAAMRA M., BIDLINGMAIER M., POSTEL-VINAY M.C., WU Z., STRASBURGER C.J., ROSS R.J. ET AL. Generation of human soluble leptin receptor by proteolytic cleavage of membrane-anchored receptors. Endocrinology 2001; 142: 4389-93.
60. SINHA M.K., STURIS J., OHANNESIAN J., MAGOSIN S., STEPHENS T., HEIMAN M.L. ET AL. Ultradian oscillations of leptin secretion in humans. Biochem Biophys Res Commun 1996; 228: 733-8.
61. BODEN G., CHEN X., MOZZOLI M., RYAN I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996; 81: 3419-23.
62. HILEMAN S.M., PIERROZ D.D., MASUZAKI H., BJØRBAEK C., EL-HASCHIMI K., BANKS WA H. ET AL. Characterization of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology 2002; 143: 775-83.
63. CARO J.F., KOLACZYNSKI J.W., NYCE M.R., OHANNESIAN J.P., OPENTANOVA I., GOLDMAN W.H. ET AL. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-61.
64. THE WELLCOME TRUST CASE CONTROL CONSORTIUM. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007: 447: 661-78.
65. WILLER C.J., SPELIOTES E.K., LOOS R.J., LI S., LINDGREN C.M., HEID I.M. ET AL. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009; 41: 25-34.
66. THORLEIFSSON G., WALTERS G.B., GUDBJARTSSON D.F., STEINTHORSDOTTIR V., SULEM P., HELGADOTTIR A. ET AL. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009; 41: 18-24.
67. LOOS R.J., LINDGREN C.M., LI S., WHEELER E., ZHAO J.H., PROKOPENKO I. ET AL. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008; 40: 768-75.
68. PETER J.C., BEKEL A., LECOURT A.C., ZIPFEL G., EFTEKHARI P., NESSLINGER M. ET AL. Anti-melanocortin-4 receptor autoantibodies in obesity. J Clin Endocrinol Metab 2009; 94: 793-800.
69. HEYMSFIELD S.B., GREENBERG A.S., FUJIOKA K., DIXON R.M., KUSHNER R., HUNT T.K. ET AL. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999; 282: 1568-75.
70. RAVUSSIN E., SMITH S.R., MITCHELL J.A., SHRINGARPURE R., SHAN K., MAIER H. ET AL. Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity 2009 [Epub ahead of print].
71. ETTINGER M.P., LITTLEJOHN T.W., SCHWARTZ S.L., WEISS S.R., MCILWAIN H.H., HEYMSFIELD S.B. ET AL. Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. JAMA 2003; 289: 1826-32.
72. OZCAN L., ERGIN A.S., LU A., CHUNG J., SARKAR S., NIE D. ET AL. Endoplasmic Reticulum Stress Plays a Central Role in Development of Leptin Resistance. Cell Metabolism 2009; 9: 35-51.
73. REINEHR T., HEBEBRAND J., FRIEDEL S., TOSCHKE A.M., BRUMM H., BIEBERMANN H., HINNEY A. Lifestyle intervention in obese children with variations in the melanocortin 4 receptor gene. Obesity 2009; 17: 382-9.